Document is current

Article History

Received: 17 September 2017

Revised: 23 April 2018

Accepted: 12 June 2018

First Online: 21 September 2018

Conflict of interest

: M.S. has received travel grants from Janssen, Eli Lilly, and AOP Orphan Pharmaceuticals, speaker honoraria from Janssen and Austroplant, workshop participation from Eli Lilly, and is recipient of a 2015 NARSAD Young Investigator Grant (23741). M.H. has received financial support from the Austrian Science Fund and the Jubilee Fund of the Austrian National Bank. G.G. is recipient of a DOC Fellowship of the Austrian Academy of Sciences at the Medical University of Vienna. G.S.K. received travel grants from Roche and Pfizer. P.B.-M. received a travel grant from AOP Orphan Pharmaceuticals AG and speaker honoraria from Janssen. T.V. received travel grants and compensation for workshop participation from Pfizer and Eli Lilly and speaker honoraria from Eli Lilly. W.W. is an employee at CBmed Ltd., Graz, Austria, has received speaker honoraria from GE Healthcare, Vienna, Austria and research support from DSD, Vienna, Austria, BSM Diagnostica, Vienna, Austria, ABX, Radeberg, Germany, and Rotem GmbH, Leipzig, Germany. S.K. has received grants/research support, consulting fees and/or honoraria within the last three years from Angelini, AOP Orphan Pharmaceuticals AG, AstraZeneca, Eli Lilly, Janssen, KRKA-Pharma, Lundbeck, Neuraxpharm, Pfizer, Pierre Fabre, Schwabe, and Servier. R.L. has received travel grants and conference speaker honoraria from AstraZeneca, Lundbeck A/S, Roche Austria GmbH, Dr. Willmar Schwabe GmbH & Co. KG, AOP Orphan Pharmaceuticals, and Janssen-Cilag Pharma Gmbh. D.W. has received lecture fees from Angelini, Lundbeck and Pfizer. The remaining authors declare that they have no conflict of interest.